Sara Mainardi

1.6k total citations
12 papers, 658 citations indexed

About

Sara Mainardi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sara Mainardi has authored 12 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Sara Mainardi's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Melanoma and MAPK Pathways (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Sara Mainardi is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Melanoma and MAPK Pathways (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Sara Mainardi collaborates with scholars based in Netherlands, Italy and Germany. Sara Mainardi's co-authors include René Bernards, Cor Lieftink, Sarah Francoz, Mariano Barbacid, Carolina Vicente‐Dueñas, Isidro Sánchez‐García, Astrid Bosma, Anirudh Prahallad, Antonio Mulero‐Sánchez and Ernest Nadal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Sara Mainardi

12 papers receiving 653 citations

Peers

Sara Mainardi
Chi-Chao Chen United States
Jonathan T. Lei United States
Matias Casás‐Selves United States
Pardeep Heir Canada
Carter J. Barger United States
Paul Howell United States
Mary J. C. Ludlam United States
Iris Z. Uras Austria
Dorine Bellanger France
Constance M. Cultraro United States
Chi-Chao Chen United States
Sara Mainardi
Citations per year, relative to Sara Mainardi Sara Mainardi (= 1×) peers Chi-Chao Chen

Countries citing papers authored by Sara Mainardi

Since Specialization
Citations

This map shows the geographic impact of Sara Mainardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Mainardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Mainardi more than expected).

Fields of papers citing papers by Sara Mainardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Mainardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Mainardi. The network helps show where Sara Mainardi may publish in the future.

Co-authorship network of co-authors of Sara Mainardi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Mainardi. A scholar is included among the top collaborators of Sara Mainardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Mainardi. Sara Mainardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mainardi, Sara, Matheus Henrique Dias, Astrid Bosma, et al.. (2024). Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in KRAS -mutant cancers. Proceedings of the National Academy of Sciences. 121(9). e2319492121–e2319492121. 9 indexed citations
2.
Mulero‐Sánchez, Antonio, Astrid Bosma, René Bernards, et al.. (2023). 1630P Phase I/Ib study of SHP2-ERK inhibition in KRASm pancreatic cancer (SHERPA trial) and preclinical identification of potential resistance markers. Annals of Oncology. 34. S902–S903. 2 indexed citations
3.
Mainardi, Sara. (2023). With a little help from my T friends: T cells increase efficacy of KRAS (G12D) inhibitors. Cell Reports Medicine. 4(2). 100950–100950. 3 indexed citations
4.
Mulero‐Sánchez, Antonio, Christel Ramirez, Aimée du Chatinier, et al.. (2023). Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma. Molecular Oncology. 17(6). 964–980. 11 indexed citations
5.
Mainardi, Sara & René Bernards. (2022). A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer. Cell Genomics. 2(2). 100100–100100. 7 indexed citations
6.
Haar, Joris van de, Salo Ooft, Louisa R. Hoes, et al.. (2022). Codon-specific KRAS mutations predict overall survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.. Journal of Clinical Oncology. 40(16_suppl). 3593–3593. 1 indexed citations
7.
Bosdriesz, Evert, Joep de Ligt, Sara Mainardi, et al.. (2018). A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells. Molecular & Cellular Proteomics. 17(10). 1892–1908. 13 indexed citations
8.
Mainardi, Sara, Antonio Mulero‐Sánchez, Anirudh Prahallad, et al.. (2018). SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo. Nature Medicine. 24(7). 961–967. 226 indexed citations
9.
Wang, Liqin, Rodrigo Leite de Oliveira, Cun Wang, et al.. (2017). High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer. Cell Reports. 21(3). 773–783. 163 indexed citations
10.
Roos, Jeroen A.D.M. de, Joost C.M. Uitdehaag, Nicole Willemsen‐Seegers, et al.. (2017). Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines. Oncotarget. 8(24). 38309–38325. 26 indexed citations
11.
Mainardi, Sara, et al.. (2013). Identification of cancer initiating cells in K-Ras driven lung adenocarcinoma. Proceedings of the National Academy of Sciences. 111(1). 255–260. 126 indexed citations
12.
Mainardi, Sara, Andrea Pelosi, Aymone Gurtner, et al.. (2009). A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. Oncogene. 28(45). 4034–4040. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi-Chao Chen Breakdown of academic impact, for papers by Jonathan T. Lei Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Pardeep Heir Breakdown of academic impact, for papers by Carter J. Barger Breakdown of academic impact, for papers by Paul Howell Breakdown of academic impact, for papers by Mary J. C. Ludlam Breakdown of academic impact, for papers by Iris Z. Uras Breakdown of academic impact, for papers by Dorine Bellanger Breakdown of academic impact, for papers by Constance M. Cultraro
Rankless by CCL
2026